AnGes, Inc.
AnGes, Inc. (AMGXF) Stock Competitors & Peer Comparison
See (AMGXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMGXF | $0.36 | +0.00% | 127.1M | -0.46 | -$0.79 | N/A |
| NONOF | $69.94 | -0.19% | 320.7B | 19.58 | $3.69 | +2.37% |
| CSLLY | $88.17 | -0.92% | 170.8B | 32.29 | $2.73 | +1.50% |
| CMXHF | $175.70 | -1.19% | 85.1B | 32.18 | $5.46 | +1.52% |
| UCBJF | $213.55 | +1.62% | 41.2B | 33.99 | $6.37 | +0.73% |
| UCBJY | $105.14 | +0.11% | 39.9B | 32.73 | $3.21 | +0.75% |
| ARGNF | $547.60 | +0.00% | 33.5B | 33.45 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $11.50 | +0.00% | 19.7B | -1150.00 | -$0.01 | N/A |
| WXIBF | $4.00 | +5.26% | 16.3B | 36.36 | $0.11 | N/A |
Stock Comparison
AMGXF vs NONOF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NONOF has a market cap of 320.7B. Regarding current trading prices, AMGXF is priced at $0.36, while NONOF trades at $69.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas NONOF's P/E ratio is 19.58. In terms of profitability, AMGXF's ROE is -0.24%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, AMGXF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NONOF's competition here
AMGXF vs CSLLY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CSLLY has a market cap of 170.8B. Regarding current trading prices, AMGXF is priced at $0.36, while CSLLY trades at $88.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CSLLY's P/E ratio is 32.29. In terms of profitability, AMGXF's ROE is -0.24%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, AMGXF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CSLLY's competition here
AMGXF vs CMXHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CMXHF has a market cap of 85.1B. Regarding current trading prices, AMGXF is priced at $0.36, while CMXHF trades at $175.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CMXHF's P/E ratio is 32.18. In terms of profitability, AMGXF's ROE is -0.24%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, AMGXF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CMXHF's competition here
AMGXF vs UCBJF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, UCBJF has a market cap of 41.2B. Regarding current trading prices, AMGXF is priced at $0.36, while UCBJF trades at $213.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas UCBJF's P/E ratio is 33.99. In terms of profitability, AMGXF's ROE is -0.24%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, AMGXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check UCBJF's competition here
AMGXF vs UCBJY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, UCBJY has a market cap of 39.9B. Regarding current trading prices, AMGXF is priced at $0.36, while UCBJY trades at $105.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas UCBJY's P/E ratio is 32.73. In terms of profitability, AMGXF's ROE is -0.24%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, AMGXF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check UCBJY's competition here
AMGXF vs ARGNF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, AMGXF is priced at $0.36, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ARGNF's P/E ratio is 33.45. In terms of profitability, AMGXF's ROE is -0.24%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, AMGXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ARGNF's competition here
AMGXF vs ODTC Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, AMGXF is priced at $0.36, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ODTC's P/E ratio is 1.07. In terms of profitability, AMGXF's ROE is -0.24%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, AMGXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ODTC's competition here
AMGXF vs IVBXF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, IVBXF has a market cap of 19.7B. Regarding current trading prices, AMGXF is priced at $0.36, while IVBXF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas IVBXF's P/E ratio is -1150.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, AMGXF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check IVBXF's competition here
AMGXF vs WXIBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, WXIBF has a market cap of 16.3B. Regarding current trading prices, AMGXF is priced at $0.36, while WXIBF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas WXIBF's P/E ratio is 36.36. In terms of profitability, AMGXF's ROE is -0.24%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, AMGXF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check WXIBF's competition here
AMGXF vs WXXWY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, WXXWY has a market cap of 16.2B. Regarding current trading prices, AMGXF is priced at $0.36, while WXXWY trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas WXXWY's P/E ratio is 36.23. In terms of profitability, AMGXF's ROE is -0.24%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, AMGXF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check WXXWY's competition here
AMGXF vs SBMFF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, AMGXF is priced at $0.36, while SBMFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SBMFF's P/E ratio is 89.21. In terms of profitability, AMGXF's ROE is -0.24%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, AMGXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SBMFF's competition here
AMGXF vs SBHMY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SBHMY has a market cap of 15.6B. Regarding current trading prices, AMGXF is priced at $0.36, while SBHMY trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SBHMY's P/E ratio is 60.34. In terms of profitability, AMGXF's ROE is -0.24%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, AMGXF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SBHMY's competition here
AMGXF vs GNMSF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, GNMSF has a market cap of 14B. Regarding current trading prices, AMGXF is priced at $0.36, while GNMSF trades at $226.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas GNMSF's P/E ratio is 13.32. In terms of profitability, AMGXF's ROE is -0.24%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, AMGXF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check GNMSF's competition here
AMGXF vs TRSBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, TRSBF has a market cap of 8.8B. Regarding current trading prices, AMGXF is priced at $0.36, while TRSBF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas TRSBF's P/E ratio is 31.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, AMGXF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check TRSBF's competition here
AMGXF vs AKBLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, AKBLF has a market cap of 6.8B. Regarding current trading prices, AMGXF is priced at $0.36, while AKBLF trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas AKBLF's P/E ratio is 46.83. In terms of profitability, AMGXF's ROE is -0.24%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, AMGXF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check AKBLF's competition here
AMGXF vs ABCZF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, AMGXF is priced at $0.36, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, AMGXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ABCZF's competition here
AMGXF vs GNNSF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, GNNSF has a market cap of 5B. Regarding current trading prices, AMGXF is priced at $0.36, while GNNSF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas GNNSF's P/E ratio is -28.83. In terms of profitability, AMGXF's ROE is -0.24%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, AMGXF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check GNNSF's competition here
AMGXF vs INCPF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, AMGXF is priced at $0.36, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas INCPF's P/E ratio is -108.67. In terms of profitability, AMGXF's ROE is -0.24%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, AMGXF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check INCPF's competition here
AMGXF vs LABFF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, AMGXF is priced at $0.36, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas LABFF's P/E ratio is 28.95. In terms of profitability, AMGXF's ROE is -0.24%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, AMGXF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check LABFF's competition here
AMGXF vs TLPPF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, AMGXF is priced at $0.36, while TLPPF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas TLPPF's P/E ratio is 150.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, AMGXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check TLPPF's competition here
AMGXF vs AAVXF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, AAVXF has a market cap of 4.4B. Regarding current trading prices, AMGXF is priced at $0.36, while AAVXF trades at $68.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas AAVXF's P/E ratio is -19.88. In terms of profitability, AMGXF's ROE is -0.24%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, AMGXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check AAVXF's competition here
AMGXF vs ZLDPF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, AMGXF is priced at $0.36, while ZLDPF trades at $61.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ZLDPF's P/E ratio is -22.70. In terms of profitability, AMGXF's ROE is -0.24%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, AMGXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ZLDPF's competition here
AMGXF vs CAMRF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CAMRF has a market cap of 4.2B. Regarding current trading prices, AMGXF is priced at $0.36, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CAMRF's P/E ratio is 56.35. In terms of profitability, AMGXF's ROE is -0.24%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, AMGXF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CAMRF's competition here
AMGXF vs SHJBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SHJBF has a market cap of 3.1B. Regarding current trading prices, AMGXF is priced at $0.36, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, AMGXF's ROE is -0.24%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, AMGXF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SHJBF's competition here
AMGXF vs REGMF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, AMGXF is priced at $0.36, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas REGMF's P/E ratio is -13.32. In terms of profitability, AMGXF's ROE is -0.24%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, AMGXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check REGMF's competition here
AMGXF vs BVNRY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BVNRY has a market cap of 2.8B. Regarding current trading prices, AMGXF is priced at $0.36, while BVNRY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BVNRY's P/E ratio is 13.83. In terms of profitability, AMGXF's ROE is -0.24%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, AMGXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BVNRY's competition here
AMGXF vs BVNKF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BVNKF has a market cap of 2.8B. Regarding current trading prices, AMGXF is priced at $0.36, while BVNKF trades at $36.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BVNKF's P/E ratio is 13.85. In terms of profitability, AMGXF's ROE is -0.24%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, AMGXF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BVNKF's competition here
AMGXF vs TKBIF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, AMGXF is priced at $0.36, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, AMGXF's ROE is -0.24%, compared to TKBIF's ROE of N/A. Regarding short-term risk, AMGXF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check TKBIF's competition here
AMGXF vs MPSYF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, AMGXF is priced at $0.36, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, AMGXF's ROE is -0.24%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, AMGXF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check MPSYF's competition here
AMGXF vs ONTTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, AMGXF is priced at $0.36, while ONTTF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ONTTF's P/E ratio is -12.78. In terms of profitability, AMGXF's ROE is -0.24%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, AMGXF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ONTTF's competition here
AMGXF vs ASPHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, AMGXF is priced at $0.36, while ASPHF trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, AMGXF's ROE is -0.24%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, AMGXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ASPHF's competition here
AMGXF vs IUGNF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, AMGXF is priced at $0.36, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, AMGXF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check IUGNF's competition here
AMGXF vs BTTAY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, AMGXF is priced at $0.36, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, AMGXF's ROE is -0.24%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, AMGXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BTTAY's competition here
AMGXF vs GLPGF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, AMGXF is priced at $0.36, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas GLPGF's P/E ratio is -5.57. In terms of profitability, AMGXF's ROE is -0.24%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, AMGXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check GLPGF's competition here
AMGXF vs BRCTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, AMGXF is priced at $0.36, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BRCTF's P/E ratio is 18.07. In terms of profitability, AMGXF's ROE is -0.24%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, AMGXF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BRCTF's competition here
AMGXF vs GENSF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, AMGXF is priced at $0.36, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas GENSF's P/E ratio is -325.12. In terms of profitability, AMGXF's ROE is -0.24%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, AMGXF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check GENSF's competition here
AMGXF vs BIESF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, AMGXF is priced at $0.36, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BIESF's P/E ratio is -44.44. In terms of profitability, AMGXF's ROE is -0.24%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, AMGXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BIESF's competition here
AMGXF vs PHMMF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, AMGXF is priced at $0.36, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PHMMF's P/E ratio is 70.13. In terms of profitability, AMGXF's ROE is -0.24%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, AMGXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PHMMF's competition here
AMGXF vs PPTDF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, AMGXF is priced at $0.36, while PPTDF trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PPTDF's P/E ratio is 15.52. In terms of profitability, AMGXF's ROE is -0.24%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, AMGXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PPTDF's competition here
AMGXF vs CSBTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CSBTF has a market cap of 1.4B. Regarding current trading prices, AMGXF is priced at $0.36, while CSBTF trades at $36.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CSBTF's P/E ratio is -277.15. In terms of profitability, AMGXF's ROE is -0.24%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, AMGXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CSBTF's competition here
AMGXF vs NURPF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, AMGXF is priced at $0.36, while NURPF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas NURPF's P/E ratio is 15.49. In terms of profitability, AMGXF's ROE is -0.24%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, AMGXF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NURPF's competition here
AMGXF vs ASCLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, AMGXF is priced at $0.36, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, AMGXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ASCLF's competition here
AMGXF vs BRAXF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, AMGXF is priced at $0.36, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, AMGXF's ROE is -0.24%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, AMGXF is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check BRAXF's competition here
AMGXF vs MEOBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, AMGXF is priced at $0.36, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, AMGXF's ROE is -0.24%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, AMGXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check MEOBF's competition here
AMGXF vs SNBIF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, AMGXF is priced at $0.36, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SNBIF's P/E ratio is -34.83. In terms of profitability, AMGXF's ROE is -0.24%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, AMGXF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check SNBIF's competition here
AMGXF vs HBMHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, AMGXF is priced at $0.36, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, AMGXF's ROE is -0.24%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, AMGXF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check HBMHF's competition here
AMGXF vs CSPHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CSPHF has a market cap of 910.9M. Regarding current trading prices, AMGXF is priced at $0.36, while CSPHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CSPHF's P/E ratio is -62.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, AMGXF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check CSPHF's competition here
AMGXF vs PHGUF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PHGUF has a market cap of 787.9M. Regarding current trading prices, AMGXF is priced at $0.36, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, AMGXF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PHGUF's competition here
AMGXF vs BPMUF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BPMUF has a market cap of 752.8M. Regarding current trading prices, AMGXF is priced at $0.36, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BPMUF's P/E ratio is 8.39. In terms of profitability, AMGXF's ROE is -0.24%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, AMGXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BPMUF's competition here
AMGXF vs IDRSF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, IDRSF has a market cap of 732.9M. Regarding current trading prices, AMGXF is priced at $0.36, while IDRSF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas IDRSF's P/E ratio is -2.12. In terms of profitability, AMGXF's ROE is -0.24%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, AMGXF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check IDRSF's competition here
AMGXF vs INRLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, INRLF has a market cap of 654.7M. Regarding current trading prices, AMGXF is priced at $0.36, while INRLF trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas INRLF's P/E ratio is -5.92. In terms of profitability, AMGXF's ROE is -0.24%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, AMGXF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check INRLF's competition here
AMGXF vs SOLTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SOLTF has a market cap of 556.5M. Regarding current trading prices, AMGXF is priced at $0.36, while SOLTF trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SOLTF's P/E ratio is -34.17. In terms of profitability, AMGXF's ROE is -0.24%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, AMGXF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SOLTF's competition here
AMGXF vs CKDXF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CKDXF has a market cap of 486.7M. Regarding current trading prices, AMGXF is priced at $0.36, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, AMGXF's ROE is -0.24%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, AMGXF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check CKDXF's competition here
AMGXF vs RAONF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, AMGXF is priced at $0.36, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas RAONF's P/E ratio is -43.33. In terms of profitability, AMGXF's ROE is -0.24%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, AMGXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check RAONF's competition here
AMGXF vs TBGNF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, AMGXF is priced at $0.36, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, AMGXF's ROE is -0.24%, compared to TBGNF's ROE of N/A. Regarding short-term risk, AMGXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check TBGNF's competition here
AMGXF vs PTCHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PTCHF has a market cap of 425.2M. Regarding current trading prices, AMGXF is priced at $0.36, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, AMGXF's ROE is -0.24%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, AMGXF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PTCHF's competition here
AMGXF vs CLVLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, AMGXF is priced at $0.36, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CLVLF's P/E ratio is 16.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, AMGXF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CLVLF's competition here
AMGXF vs VBIZF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, VBIZF has a market cap of 393.2M. Regarding current trading prices, AMGXF is priced at $0.36, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas VBIZF's P/E ratio is 18.90. In terms of profitability, AMGXF's ROE is -0.24%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, AMGXF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check VBIZF's competition here
AMGXF vs CLVLY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CLVLY has a market cap of 388.5M. Regarding current trading prices, AMGXF is priced at $0.36, while CLVLY trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CLVLY's P/E ratio is 15.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, AMGXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CLVLY's competition here
AMGXF vs CLTEF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CLTEF has a market cap of 387.7M. Regarding current trading prices, AMGXF is priced at $0.36, while CLTEF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CLTEF's P/E ratio is -5.42. In terms of profitability, AMGXF's ROE is -0.24%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, AMGXF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CLTEF's competition here
AMGXF vs NWBO Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NWBO has a market cap of 377.6M. Regarding current trading prices, AMGXF is priced at $0.36, while NWBO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas NWBO's P/E ratio is -4.32. In terms of profitability, AMGXF's ROE is -0.24%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, AMGXF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NWBO's competition here
AMGXF vs HLOSF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, HLOSF has a market cap of 376M. Regarding current trading prices, AMGXF is priced at $0.36, while HLOSF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas HLOSF's P/E ratio is -11.08. In terms of profitability, AMGXF's ROE is -0.24%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, AMGXF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check HLOSF's competition here
AMGXF vs CYDY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CYDY has a market cap of 367.9M. Regarding current trading prices, AMGXF is priced at $0.36, while CYDY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CYDY's P/E ratio is -14.92. In terms of profitability, AMGXF's ROE is -0.24%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, AMGXF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CYDY's competition here
AMGXF vs IVEVF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, AMGXF is priced at $0.36, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, AMGXF's ROE is -0.24%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, AMGXF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check IVEVF's competition here
AMGXF vs PBBIF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, AMGXF is priced at $0.36, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, AMGXF's ROE is -0.24%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, AMGXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PBBIF's competition here
AMGXF vs PRRUF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, AMGXF is priced at $0.36, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, AMGXF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PRRUF's competition here
AMGXF vs BXPHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BXPHF has a market cap of 277.1M. Regarding current trading prices, AMGXF is priced at $0.36, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BXPHF's P/E ratio is -14.13. In terms of profitability, AMGXF's ROE is -0.24%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, AMGXF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BXPHF's competition here
AMGXF vs ORYZF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, AMGXF is priced at $0.36, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, AMGXF's ROE is -0.24%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, AMGXF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ORYZF's competition here
AMGXF vs AVCTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, AVCTF has a market cap of 246.5M. Regarding current trading prices, AMGXF is priced at $0.36, while AVCTF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas AVCTF's P/E ratio is -5.79. In terms of profitability, AMGXF's ROE is -0.24%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, AMGXF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check AVCTF's competition here
AMGXF vs HNSBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, AMGXF is priced at $0.36, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas HNSBF's P/E ratio is -3.04. In terms of profitability, AMGXF's ROE is -0.24%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, AMGXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check HNSBF's competition here
AMGXF vs NWPHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, AMGXF is priced at $0.36, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas NWPHF's P/E ratio is N/A. In terms of profitability, AMGXF's ROE is -0.24%, compared to NWPHF's ROE of N/A. Regarding short-term risk, AMGXF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NWPHF's competition here
AMGXF vs MDCLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, MDCLF has a market cap of 230.8M. Regarding current trading prices, AMGXF is priced at $0.36, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, AMGXF's ROE is -0.24%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, AMGXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check MDCLF's competition here
AMGXF vs SLNCF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, AMGXF is priced at $0.36, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, AMGXF's ROE is -0.24%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, AMGXF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SLNCF's competition here
AMGXF vs BOVNF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, AMGXF is priced at $0.36, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, AMGXF's ROE is -0.24%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, AMGXF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BOVNF's competition here
AMGXF vs FPHAF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, AMGXF is priced at $0.36, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, AMGXF's ROE is -0.24%, compared to FPHAF's ROE of N/A. Regarding short-term risk, AMGXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check FPHAF's competition here
AMGXF vs VSBC Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, AMGXF is priced at $0.36, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas VSBC's P/E ratio is N/A. In terms of profitability, AMGXF's ROE is -0.24%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, AMGXF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check VSBC's competition here
AMGXF vs FGHQF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, AMGXF is priced at $0.36, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, AMGXF's ROE is -0.24%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, AMGXF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check FGHQF's competition here
AMGXF vs CAIHF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CAIHF has a market cap of 204.9M. Regarding current trading prices, AMGXF is priced at $0.36, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CAIHF's P/E ratio is 7.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, AMGXF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check CAIHF's competition here
AMGXF vs BSEM Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BSEM has a market cap of 192.8M. Regarding current trading prices, AMGXF is priced at $0.36, while BSEM trades at $11.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BSEM's P/E ratio is 8.03. In terms of profitability, AMGXF's ROE is -0.24%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, AMGXF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BSEM's competition here
AMGXF vs SPHDF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SPHDF has a market cap of 190.7M. Regarding current trading prices, AMGXF is priced at $0.36, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SPHDF's P/E ratio is -3.19. In terms of profitability, AMGXF's ROE is -0.24%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, AMGXF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SPHDF's competition here
AMGXF vs NGENF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NGENF has a market cap of 186.6M. Regarding current trading prices, AMGXF is priced at $0.36, while NGENF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas NGENF's P/E ratio is -9.14. In terms of profitability, AMGXF's ROE is -0.24%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, AMGXF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NGENF's competition here
AMGXF vs CMVLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, CMVLF has a market cap of 186M. Regarding current trading prices, AMGXF is priced at $0.36, while CMVLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas CMVLF's P/E ratio is -3.85. In terms of profitability, AMGXF's ROE is -0.24%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, AMGXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check CMVLF's competition here
AMGXF vs GNFTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, AMGXF is priced at $0.36, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas GNFTF's P/E ratio is 93.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, AMGXF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check GNFTF's competition here
AMGXF vs ADOCY Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, AMGXF is priced at $0.36, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, AMGXF's ROE is -0.24%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, AMGXF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ADOCY's competition here
AMGXF vs BRIBF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, AMGXF is priced at $0.36, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, AMGXF's ROE is -0.24%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, AMGXF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check BRIBF's competition here
AMGXF vs OPORF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, AMGXF is priced at $0.36, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas OPORF's P/E ratio is 12.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, AMGXF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check OPORF's competition here
AMGXF vs MLLCF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, AMGXF is priced at $0.36, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, AMGXF's ROE is -0.24%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, AMGXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check MLLCF's competition here
AMGXF vs SCNLF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, SCNLF has a market cap of 135.4M. Regarding current trading prices, AMGXF is priced at $0.36, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, AMGXF's ROE is -0.24%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, AMGXF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check SCNLF's competition here
AMGXF vs AAPGV Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, AMGXF is priced at $0.36, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas AAPGV's P/E ratio is N/A. In terms of profitability, AMGXF's ROE is -0.24%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, AMGXF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check AAPGV's competition here
AMGXF vs IPHYF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, IPHYF has a market cap of 120.7M. Regarding current trading prices, AMGXF is priced at $0.36, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas IPHYF's P/E ratio is -1.82. In terms of profitability, AMGXF's ROE is -0.24%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, AMGXF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check IPHYF's competition here
AMGXF vs PSTTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, AMGXF is priced at $0.36, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, AMGXF's ROE is -0.24%, compared to PSTTF's ROE of N/A. Regarding short-term risk, AMGXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PSTTF's competition here
AMGXF vs EPRXF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, AMGXF is priced at $0.36, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, AMGXF's ROE is -0.24%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, AMGXF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check EPRXF's competition here
AMGXF vs ADOIF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, AMGXF is priced at $0.36, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, AMGXF's ROE is -0.24%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, AMGXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check ADOIF's competition here
AMGXF vs JWCTF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, AMGXF is priced at $0.36, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, AMGXF's ROE is -0.24%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, AMGXF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check JWCTF's competition here
AMGXF vs TRGNF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, TRGNF has a market cap of 92.7M. Regarding current trading prices, AMGXF is priced at $0.36, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, AMGXF's ROE is -0.24%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, AMGXF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check TRGNF's competition here
AMGXF vs PBIGF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PBIGF has a market cap of 90.9M. Regarding current trading prices, AMGXF is priced at $0.36, while PBIGF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PBIGF's P/E ratio is -7.62. In terms of profitability, AMGXF's ROE is -0.24%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, AMGXF is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check PBIGF's competition here
AMGXF vs MCURF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, AMGXF is priced at $0.36, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas MCURF's P/E ratio is -16.90. In terms of profitability, AMGXF's ROE is -0.24%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, AMGXF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check MCURF's competition here
AMGXF vs ATGGF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, ATGGF has a market cap of 79.4M. Regarding current trading prices, AMGXF is priced at $0.36, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas ATGGF's P/E ratio is N/A. In terms of profitability, AMGXF's ROE is -0.24%, compared to ATGGF's ROE of -0.76%. Regarding short-term risk, AMGXF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check ATGGF's competition here
AMGXF vs PRNAF Comparison July 2025
AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMGXF stands at 127.1M. In comparison, PRNAF has a market cap of 79M. Regarding current trading prices, AMGXF is priced at $0.36, while PRNAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMGXF currently has a P/E ratio of -0.46, whereas PRNAF's P/E ratio is -0.30. In terms of profitability, AMGXF's ROE is -0.24%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, AMGXF is less volatile compared to PRNAF. This indicates potentially lower risk in terms of short-term price fluctuations for AMGXF.Check PRNAF's competition here